MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

NCT03799913 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

BIOLOGICAL: anti-MESO CAR-T cells
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Zhejiang University

Collaborators

[object Object]
[object Object]